Efficacy of a Low-Molecular-Weight Heparin (Bemiparin) in the Treatment of Chronic Foot Ulcers in Diabetic Patients

NCT00399425 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

84

Enrollment

OTHER

Sponsor class

Conditions

Foot Ulcer, Diabetic
Diabetic Angiopathies

Interventions

DRUG: bemiparin (low molecular weight heparin)

Sponsor

Spanish National Health System

Collaborators

[object Object]
[object Object]